If a woman is not ovulating by herself then ovulation induction may be required. The most common causes of failure to ovulate are stress, weight fluctuations and Polycystic Ovarian Syndrome (P.C.O.S.). Other causes may include disorders of the pituitary gland, thyroid gland and raised prolactin levels. In some cases failure of ovulation is due to the ovarian failure. This may occur following treatment for cancer or may be the start of the menopause - premature ovarian failure.
If a woman has an irregular menstrual cycle, monitoring with ultrasound scans (follicle tracking) and hormone assessments may help to identify the fertile time of the month and so improve the chances of natural conception.
Before ovulation problems can be treated it is important to undertake certian tests to establish the cause. These tests include an ultrasound scan of the ovaries and womb and blood tests to measure a range of hormones including thyroid, prolactin, FSH, LH, Testosterone and other androgens (male hormones). It is also important to ensure that the ovary is capable of responding to the drug treatment. One possible cause of failed ovulation is ovarian failure more commonly known as the menopause. If the FSH (> 20) level is high when measured at the start of a period, ovarian failure is likely. In this case drug treatment will not help.
If ovulation is not occurring, then drugs may be administered with the onset of menstruation to stimulate egg production. If tablets are not effective then more powerful fertility injections may be necessary to stimulate egg production in the ovaries.
Ovulation is induced using one of two main drug regimen:
The response to any drugs given is monitored by ultrasound scans. When follicles have reached an appropriate size intercourse is advised, or an injection of hCG is given to facilitate the timing of intercourse or IUI. Individual responses to treatment can be unpredictable and if, during the monitoring, the response is insufficient or too strong, the cycle may have to be cancelled and restarted as appropriate. If the response to the drugs is satisfactory, treatment usually continues for 6 cycles; treatment cycles can be carried out consecutively without a break. Potential side effects are mainly related to the drugs. Multiple pregnancies are a risk of ovulation induction treatments. Twins can result in up to 10% of cases with clomiphene treatment, and 20% with gonadotrophins. Triplets may also occur in around 1% of cases. With careful monitoring the risk of multiple pregnancy is reduced but not eliminated.
Women with PCOS who are not ovulating are normally given Clomid as first line treatment and usually respond very well to this. Two alternatives are available:
See also patient information booklet for further information
Freedom of Information
|
Disclaimer
|
Accessibility
|
Sitemap
© 2012 Copyright University Hospitals Coventry and Warwickshire NHS Trust
To support our hospitals and make a donation visit www.uhcwcharity.org
This site uses automatic translation software provided by Google. The Trust cannot verify its accuracy and you should not rely on the information translated. If you have a query, please contact the Patient Advice and Liaison team or your doctor/nurse.
